chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Peripheral swelling, Pruritus, Rash erythematous, Urticaria
Clinical narrative: ITCHINESS TO THE HEAD/ITCHINESS THROUGHOUT THE BODY; HIVES THROUGHOUT THE BODY; SWELLING TO THE LEFT ARM; This spontaneous report received from a patient concerned a 41 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included sulpha allergies. The patient experienced drug allergy when treated with bupropion hydrochloride. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978) dose was not reported, administered to left deltoid on 01-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 01-APR-2021, the subject experienced swelling to the left arm. On 02-APR-2021, the subject experienced itchiness to the head/itchiness throughout the body. On 02-APR-2021, the subject experienced hives throughout the body. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from swelling to the left arm on 02-APR-2021, and was recovering from itchiness to the head/itchiness throughout the body, and hives throughout the body. This report was non-serious.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Peripheral swelling, Pruritus, Urticaria
Clinical narrative: ITCHINESS TO THE HEAD/ITCHINESS THROUGHOUT THE BODY; HIVES THROUGHOUT THE BODY; SWELLING TO THE LEFT ARM; This spontaneous report received from a patient concerned a 41 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included sulpha allergies. The patient experienced drug allergy when treated with bupropion hydrochloride. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978) dose was not reported, administered to left deltoid on 01-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 01-APR-2021, the subject experienced swelling to the left arm. On 02-APR-2021, the subject experienced itchiness to the head/itchiness throughout the body. On 02-APR-2021, the subject experienced hives throughout the body. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from swelling to the left arm on 02-APR-2021, and was recovering from itchiness to the head/itchiness throughout the body, and hives throughout the body. This report was non-serious.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chills, Dizziness, Dry mouth, Fatigue, Mental fatigue
Clinical narrative: Patient received his first of the series of two Covid vaccinations on March 13, 2021. He was scheduled for his second dose on Friday, April 9, 2021; however, he did not show up for the appointment.  Two phone calls were made to his phone on April 9 that were both unanswered.  We learned of his death on Monday, April 12, from a media post.  Dr., Medical Director of the Health Center, placed a call to the county coroner on April 15 to inquire and make him aware of his Covid-19 vaccination.  Per the coroner, on an undetermined date between March 13 and April 9, 2021, Patient reportedly developed symptoms including back pain and polydipsia.  He stated that Patient went to an undetermined clinic the week of April 4 ? 9 and was tested for Covid-19. From the description of from the patient's partner, Patient probably had a rapid Covid test and a PCR Covid test. These reportedly returned as negative for Covid.  According to  Coroner, they found him deceased in his apartment on April 10, 2021. Coroner sent the body to forensic pathologist, Dr., for an autopsy. The autopsy in incomplete at this time, but Dr.  told Coroner that the ?organs looked anemic? and ?the lungs looked bad.? The final autopsy findings will not be available for approximately 1 ? 2 weeks. There are other reports that Patient was obese and had voluntarily lost about 30 pounds recently but ?didn?t feel good.?
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Muscle fatigue, Neuropathy peripheral, Pyrexia, Thirst, Vision blurred
Clinical narrative: Patient received his first of the series of two Covid vaccinations on March 13, 2021. He was scheduled for his second dose on Friday, April 9, 2021; however, he did not show up for the appointment.  Two phone calls were made to his phone on April 9 that were both unanswered.  We learned of his death on Monday, April 12, from a media post.  Dr., Medical Director of the Health Center, placed a call to the county coroner on April 15 to inquire and make him aware of his Covid-19 vaccination.  Per the coroner, on an undetermined date between March 13 and April 9, 2021, Patient reportedly developed symptoms including back pain and polydipsia.  He stated that Patient went to an undetermined clinic the week of April 4 ? 9 and was tested for Covid-19. From the description of from the patient's partner, Patient probably had a rapid Covid test and a PCR Covid test. These reportedly returned as negative for Covid.  According to  Coroner, they found him deceased in his apartment on April 10, 2021. Coroner sent the body to forensic pathologist, Dr., for an autopsy. The autopsy in incomplete at this time, but Dr.  told Coroner that the ?organs looked anemic? and ?the lungs looked bad.? The final autopsy findings will not be available for approximately 1 ? 2 weeks. There are other reports that Patient was obese and had voluntarily lost about 30 pounds recently but ?didn?t feel good.?
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Weight decreased
Clinical narrative: Patient received his first of the series of two Covid vaccinations on March 13, 2021. He was scheduled for his second dose on Friday, April 9, 2021; however, he did not show up for the appointment.  Two phone calls were made to his phone on April 9 that were both unanswered.  We learned of his death on Monday, April 12, from a media post.  Dr., Medical Director of the Health Center, placed a call to the county coroner on April 15 to inquire and make him aware of his Covid-19 vaccination.  Per the coroner, on an undetermined date between March 13 and April 9, 2021, Patient reportedly developed symptoms including back pain and polydipsia.  He stated that Patient went to an undetermined clinic the week of April 4 ? 9 and was tested for Covid-19. From the description of from the patient's partner, Patient probably had a rapid Covid test and a PCR Covid test. These reportedly returned as negative for Covid.  According to  Coroner, they found him deceased in his apartment on April 10, 2021. Coroner sent the body to forensic pathologist, Dr., for an autopsy. The autopsy in incomplete at this time, but Dr.  told Coroner that the ?organs looked anemic? and ?the lungs looked bad.? The final autopsy findings will not be available for approximately 1 ? 2 weeks. There are other reports that Patient was obese and had voluntarily lost about 30 pounds recently but ?didn?t feel good.?
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Autopsy, Back pain, Death, Malaise, Obesity
Clinical narrative: Patient received his first of the series of two Covid vaccinations on March 13, 2021. He was scheduled for his second dose on Friday, April 9, 2021; however, he did not show up for the appointment.  Two phone calls were made to his phone on April 9 that were both unanswered.  We learned of his death on Monday, April 12, from a media post.  Dr., Medical Director of the Health Center, placed a call to the county coroner on April 15 to inquire and make him aware of his Covid-19 vaccination.  Per the coroner, on an undetermined date between March 13 and April 9, 2021, Patient reportedly developed symptoms including back pain and polydipsia.  He stated that Patient went to an undetermined clinic the week of April 4 ? 9 and was tested for Covid-19. From the description of from the patient's partner, Patient probably had a rapid Covid test and a PCR Covid test. These reportedly returned as negative for Covid.  According to  Coroner, they found him deceased in his apartment on April 10, 2021. Coroner sent the body to forensic pathologist, Dr., for an autopsy. The autopsy in incomplete at this time, but Dr.  told Coroner that the ?organs looked anemic? and ?the lungs looked bad.? The final autopsy findings will not be available for approximately 1 ? 2 weeks. There are other reports that Patient was obese and had voluntarily lost about 30 pounds recently but ?didn?t feel good.?
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Polydipsia, SARS-CoV-2 test negative, Weight decreased
Clinical narrative: Patient received his first of the series of two Covid vaccinations on March 13, 2021. He was scheduled for his second dose on Friday, April 9, 2021; however, he did not show up for the appointment.  Two phone calls were made to his phone on April 9 that were both unanswered.  We learned of his death on Monday, April 12, from a media post.  Dr., Medical Director of the Health Center, placed a call to the county coroner on April 15 to inquire and make him aware of his Covid-19 vaccination.  Per the coroner, on an undetermined date between March 13 and April 9, 2021, Patient reportedly developed symptoms including back pain and polydipsia.  He stated that Patient went to an undetermined clinic the week of April 4 ? 9 and was tested for Covid-19. From the description of from the patient's partner, Patient probably had a rapid Covid test and a PCR Covid test. These reportedly returned as negative for Covid.  According to  Coroner, they found him deceased in his apartment on April 10, 2021. Coroner sent the body to forensic pathologist, Dr., for an autopsy. The autopsy in incomplete at this time, but Dr.  told Coroner that the ?organs looked anemic? and ?the lungs looked bad.? The final autopsy findings will not be available for approximately 1 ? 2 weeks. There are other reports that Patient was obese and had voluntarily lost about 30 pounds recently but ?didn?t feel good.?
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Chills, Fatigue, Feeling abnormal, Headache, Immediate post-injection reaction
Clinical narrative: SORENESS; FLU LIKE SYMPTOMS (SHORTNESS OF BREATH, CHILLS, FEVER AND HEADACHE ); COULD NOT FOCUS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805020, expiry: UNKNOWN) dose was not reported, administered on 28-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, Laboratory data included: COVID-19 virus test (NR: not provided) negative. On an unspecified date, the subject experienced soreness, flu like symptoms (shortness of breath, chills, fever and headache ), and could not focus. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from soreness, flu like symptoms (shortness of breath, chills, fever and headache ), and could not focus. This report was non-serious.; Sender's Comments: V0: Medical assessment comment is not required as per standard procedure as case assessed as non-serious.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Nausea, Pain, Pyrexia, SARS-CoV-2 test negative, Vomiting
Clinical narrative: SORENESS; FLU LIKE SYMPTOMS (SHORTNESS OF BREATH, CHILLS, FEVER AND HEADACHE ); COULD NOT FOCUS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805020, expiry: UNKNOWN) dose was not reported, administered on 28-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, Laboratory data included: COVID-19 virus test (NR: not provided) negative. On an unspecified date, the subject experienced soreness, flu like symptoms (shortness of breath, chills, fever and headache ), and could not focus. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from soreness, flu like symptoms (shortness of breath, chills, fever and headache ), and could not focus. This report was non-serious.; Sender's Comments: V0: Medical assessment comment is not required as per standard procedure as case assessed as non-serious.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Disturbance in attention, Influenza like illness, Pain, SARS-CoV-2 test
Clinical narrative: SORENESS; FLU LIKE SYMPTOMS (SHORTNESS OF BREATH, CHILLS, FEVER AND HEADACHE ); COULD NOT FOCUS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805020, expiry: UNKNOWN) dose was not reported, administered on 28-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, Laboratory data included: COVID-19 virus test (NR: not provided) negative. On an unspecified date, the subject experienced soreness, flu like symptoms (shortness of breath, chills, fever and headache ), and could not focus. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from soreness, flu like symptoms (shortness of breath, chills, fever and headache ), and could not focus. This report was non-serious.; Sender's Comments: V0: Medical assessment comment is not required as per standard procedure as case assessed as non-serious.
Age: 31.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Head injury, Loss of consciousness
Clinical narrative: Received the shot in left shoulder. Was browsing phone for about 30 seconds to a minute. Felt a rising sensation in the esophagus. Felt as though nausea was impending. Sensation rose into skull in "crawling waves". Skull felt heavy. Interpreted the sensation as disorientation. Asked pharmacist if dizziness was normal with the vaccine. Woke up a few seconds later picking myself up off the floor.
Age: 31.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Disorientation, Dizziness, Head discomfort, Loss of consciousness, Nausea
Clinical narrative: Received the shot in left shoulder. Was browsing phone for about 30 seconds to a minute. Felt a rising sensation in the esophagus. Felt as though nausea was impending. Sensation rose into skull in "crawling waves". Skull felt heavy. Interpreted the sensation as disorientation. Asked pharmacist if dizziness was normal with the vaccine. Woke up a few seconds later picking myself up off the floor.
Age: 31.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Oesophageal disorder
Clinical narrative: Received the shot in left shoulder. Was browsing phone for about 30 seconds to a minute. Felt a rising sensation in the esophagus. Felt as though nausea was impending. Sensation rose into skull in "crawling waves". Skull felt heavy. Interpreted the sensation as disorientation. Asked pharmacist if dizziness was normal with the vaccine. Woke up a few seconds later picking myself up off the floor.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray, Dyspnoea, Electrocardiogram abnormal, Heart rate irregular, Pulmonary embolism
Clinical narrative: 2 days after the second Pfizer Covid vaccine patient was admitted to hospital with diagnosis of bilateral pulmonary emboli, right peroneal vein DVT.  Showed right ventricular strain.  Anticoagulated and discharged home after 2 days.  On anticoagulation. Follow-up 12 days later me back to baseline.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tachycardia, Thrombosis, Ventilation/perfusion scan
Clinical narrative: 2 days after the second Pfizer Covid vaccine patient was admitted to hospital with diagnosis of bilateral pulmonary emboli, right peroneal vein DVT.  Showed right ventricular strain.  Anticoagulated and discharged home after 2 days.  On anticoagulation. Follow-up 12 days later me back to baseline.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angiogram pulmonary abnormal, Anticoagulant therapy, Deep vein thrombosis, Electrocardiogram ST-T segment abnormal, Fibrin D dimer
Clinical narrative: 2 days after the second Pfizer Covid vaccine patient was admitted to hospital with diagnosis of bilateral pulmonary emboli, right peroneal vein DVT.  Showed right ventricular strain.  Anticoagulated and discharged home after 2 days.  On anticoagulation. Follow-up 12 days later me back to baseline.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pulmonary embolism
Clinical narrative: 2 days after the second Pfizer Covid vaccine patient was admitted to hospital with diagnosis of bilateral pulmonary emboli, right peroneal vein DVT.  Showed right ventricular strain.  Anticoagulated and discharged home after 2 days.  On anticoagulation. Follow-up 12 days later me back to baseline.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Headache, Pain, Pyrexia
Clinical narrative: BODY ACHES; FEVER; HEADACHE; TIREDNESS; This spontaneous report received from a patient concerned a 54 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included penicillin allergy, and sulfonamide allergy. The patient experienced drug allergy when treated with codeine, and ondansetron for drug used for unknown indication. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 11:00 for prophylactic vaccination. No concomitant medications were reported. On 07-APR-2021, the subject experienced body aches. On 07-APR-2021, the subject experienced fever. On 07-APR-2021, the subject experienced headache. On 07-APR-2021, the subject experienced tiredness. Laboratory data included: Body temperature (NR: not provided) 100 F. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from fever, headache, body aches, and tiredness. This report was non-serious.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Fatigue, Headache, Pain, Pyrexia
Clinical narrative: BODY ACHES; FEVER; HEADACHE; TIREDNESS; This spontaneous report received from a patient concerned a 54 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included penicillin allergy, and sulfonamide allergy. The patient experienced drug allergy when treated with codeine, and ondansetron for drug used for unknown indication. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 11:00 for prophylactic vaccination. No concomitant medications were reported. On 07-APR-2021, the subject experienced body aches. On 07-APR-2021, the subject experienced fever. On 07-APR-2021, the subject experienced headache. On 07-APR-2021, the subject experienced tiredness. Laboratory data included: Body temperature (NR: not provided) 100 F. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from fever, headache, body aches, and tiredness. This report was non-serious.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site vesicles
Clinical narrative: TWO BLISTERS AT INJECTION SITE; RASH AT THE INJECTION SITE AROUND THE BAND-AID; CHILLS; NAUSEA; WEAKNESS; PAIN AT THE INJECTION SITE; This spontaneous report received from a patient concerned a 26 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A, and expiry: 21/JUN/2021) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 07-APR-2021, the subject experienced chills. On 07-APR-2021, the subject experienced nausea. On 07-APR-2021, the subject experienced weakness. On 07-APR-2021, the subject experienced pain at the injection site. On 08-APR-2021, the subject experienced rash at the injection site around the band-aid. On 09-APR-2021, the subject experienced two blisters at injection site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from rash at the injection site around the band-aid, chills, nausea, weakness, and pain at the injection site on APR-2021, and had not recovered from two blisters at injection site. This report was non-serious.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Chills, Injection site pain, Injection site rash, Injection site vesicles
Clinical narrative: TWO BLISTERS AT INJECTION SITE; RASH AT THE INJECTION SITE AROUND THE BAND-AID; CHILLS; NAUSEA; WEAKNESS; PAIN AT THE INJECTION SITE; This spontaneous report received from a patient concerned a 26 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A, and expiry: 21/JUN/2021) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 07-APR-2021, the subject experienced chills. On 07-APR-2021, the subject experienced nausea. On 07-APR-2021, the subject experienced weakness. On 07-APR-2021, the subject experienced pain at the injection site. On 08-APR-2021, the subject experienced rash at the injection site around the band-aid. On 09-APR-2021, the subject experienced two blisters at injection site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from rash at the injection site around the band-aid, chills, nausea, weakness, and pain at the injection site on APR-2021, and had not recovered from two blisters at injection site. This report was non-serious.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea
Clinical narrative: TWO BLISTERS AT INJECTION SITE; RASH AT THE INJECTION SITE AROUND THE BAND-AID; CHILLS; NAUSEA; WEAKNESS; PAIN AT THE INJECTION SITE; This spontaneous report received from a patient concerned a 26 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A, and expiry: 21/JUN/2021) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 07-APR-2021, the subject experienced chills. On 07-APR-2021, the subject experienced nausea. On 07-APR-2021, the subject experienced weakness. On 07-APR-2021, the subject experienced pain at the injection site. On 08-APR-2021, the subject experienced rash at the injection site around the band-aid. On 09-APR-2021, the subject experienced two blisters at injection site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from rash at the injection site around the band-aid, chills, nausea, weakness, and pain at the injection site on APR-2021, and had not recovered from two blisters at injection site. This report was non-serious.
Age: 21.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Hyperhidrosis, Immediate post-injection reaction, Nausea
Clinical narrative: SWEATING; DIZZINESS/LIGHTHEADEDNESS; ACHING; CHILLS; NAUSEA; SLIGHT HEADACHE; This spontaneous report received from a parent concerned a 21 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included intellectual disabilities. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, and batch number: 043A21A expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 07-APR-2021, the subject experienced sweating. On 07-APR-2021, the subject experienced dizziness/lightheadedness. On 07-APR-2021, the subject experienced aching. On 07-APR-2021, the subject experienced chills. On 07-APR-2021, the subject experienced nausea. On 07-APR-2021, the subject experienced slight headache. Treatment medications (dates unspecified) included: paracetamol, and ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sweating, dizziness/lightheadedness, and nausea on 07-APR-2021, and aching, chills, and slight headache on 08-APR-2021. This report was non-serious.
Age: 21.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Dizziness, Headache, Hyperhidrosis, Nausea
Clinical narrative: SWEATING; DIZZINESS/LIGHTHEADEDNESS; ACHING; CHILLS; NAUSEA; SLIGHT HEADACHE; This spontaneous report received from a parent concerned a 21 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included intellectual disabilities. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, and batch number: 043A21A expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 07-APR-2021, the subject experienced sweating. On 07-APR-2021, the subject experienced dizziness/lightheadedness. On 07-APR-2021, the subject experienced aching. On 07-APR-2021, the subject experienced chills. On 07-APR-2021, the subject experienced nausea. On 07-APR-2021, the subject experienced slight headache. Treatment medications (dates unspecified) included: paracetamol, and ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sweating, dizziness/lightheadedness, and nausea on 07-APR-2021, and aching, chills, and slight headache on 08-APR-2021. This report was non-serious.
Age: 21.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain
Clinical narrative: SWEATING; DIZZINESS/LIGHTHEADEDNESS; ACHING; CHILLS; NAUSEA; SLIGHT HEADACHE; This spontaneous report received from a parent concerned a 21 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included intellectual disabilities. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, and batch number: 043A21A expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 07-APR-2021, the subject experienced sweating. On 07-APR-2021, the subject experienced dizziness/lightheadedness. On 07-APR-2021, the subject experienced aching. On 07-APR-2021, the subject experienced chills. On 07-APR-2021, the subject experienced nausea. On 07-APR-2021, the subject experienced slight headache. Treatment medications (dates unspecified) included: paracetamol, and ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sweating, dizziness/lightheadedness, and nausea on 07-APR-2021, and aching, chills, and slight headache on 08-APR-2021. This report was non-serious.
Age: 15.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cardiac arrest, Intensive care
Clinical narrative: VR was under 16 YOA - Improper treatment
Age: 15.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal pain upper, Abnormal faeces, Cardiac arrest, Dysstasia, Insomnia
Clinical narrative: VR was under 16 YOA - Improper treatment
Age: 15.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Lethargy, Pyrexia, SARS-CoV-2 test, Unresponsive to stimuli
Clinical narrative: VR was under 16 YOA - Improper treatment
Age: 15.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: VR was under 16 YOA - Improper treatment
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Condition aggravated, Headache, Migraine, Nausea, Restlessness
Clinical narrative: PANIC ATTACK; ALARMING UPTICK IN MIGRAINE ACTIVITY; LESS SEVERE HEADACHE; NAUSEA; TEMPERATURE ELEVATION; RESTLESSNESS; JITTERINESS; FLU LIKE SYMPTOMS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's concurrent conditions included migraine.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805025, and batch number: 1805025 expiry: UNKNOWN) dose was not reported, 1 total, administered on 12-MAR-2021 14:30 for prophylactic vaccination. Concomitant medications included sumatriptan for migraine. On 12-MAR-2021, the subject experienced restlessness. On 12-MAR-2021, the subject experienced jitteriness. On 12-MAR-2021, the subject experienced flu like symptoms. On 12-MAR-2021, the subject experienced alarming uptick in migraine activity. On 12-MAR-2021, the subject experienced less severe headache. On 12-MAR-2021, the subject experienced nausea. On 12-MAR-2021, the subject experienced temperature elevation. Laboratory data included: Body temperature (NR: not provided) 99.7 degree. On 13-MAR-2021, the subject experienced panic attack. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from temperature elevation on 2021, and the outcome of restlessness, nausea, jitteriness, flu like symptoms, less severe headache, panic attack and alarming uptick in migraine activity was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Feeling jittery, Headache, Influenza like illness, Migraine
Clinical narrative: PANIC ATTACK; ALARMING UPTICK IN MIGRAINE ACTIVITY; LESS SEVERE HEADACHE; NAUSEA; TEMPERATURE ELEVATION; RESTLESSNESS; JITTERINESS; FLU LIKE SYMPTOMS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's concurrent conditions included migraine.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805025, and batch number: 1805025 expiry: UNKNOWN) dose was not reported, 1 total, administered on 12-MAR-2021 14:30 for prophylactic vaccination. Concomitant medications included sumatriptan for migraine. On 12-MAR-2021, the subject experienced restlessness. On 12-MAR-2021, the subject experienced jitteriness. On 12-MAR-2021, the subject experienced flu like symptoms. On 12-MAR-2021, the subject experienced alarming uptick in migraine activity. On 12-MAR-2021, the subject experienced less severe headache. On 12-MAR-2021, the subject experienced nausea. On 12-MAR-2021, the subject experienced temperature elevation. Laboratory data included: Body temperature (NR: not provided) 99.7 degree. On 13-MAR-2021, the subject experienced panic attack. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from temperature elevation on 2021, and the outcome of restlessness, nausea, jitteriness, flu like symptoms, less severe headache, panic attack and alarming uptick in migraine activity was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Nausea, Panic attack, Pyrexia, Restlessness
Clinical narrative: PANIC ATTACK; ALARMING UPTICK IN MIGRAINE ACTIVITY; LESS SEVERE HEADACHE; NAUSEA; TEMPERATURE ELEVATION; RESTLESSNESS; JITTERINESS; FLU LIKE SYMPTOMS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's concurrent conditions included migraine.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805025, and batch number: 1805025 expiry: UNKNOWN) dose was not reported, 1 total, administered on 12-MAR-2021 14:30 for prophylactic vaccination. Concomitant medications included sumatriptan for migraine. On 12-MAR-2021, the subject experienced restlessness. On 12-MAR-2021, the subject experienced jitteriness. On 12-MAR-2021, the subject experienced flu like symptoms. On 12-MAR-2021, the subject experienced alarming uptick in migraine activity. On 12-MAR-2021, the subject experienced less severe headache. On 12-MAR-2021, the subject experienced nausea. On 12-MAR-2021, the subject experienced temperature elevation. Laboratory data included: Body temperature (NR: not provided) 99.7 degree. On 13-MAR-2021, the subject experienced panic attack. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from temperature elevation on 2021, and the outcome of restlessness, nausea, jitteriness, flu like symptoms, less severe headache, panic attack and alarming uptick in migraine activity was not reported. This report was non-serious.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fatigue, Lymphadenopathy, Neck pain, Palpitations, SARS-CoV-2 test
Clinical narrative: developed thyroiditis went to ER following with endocronologist. thinks might be related to vaccine. updating previous report per request
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Thyroid pain, Thyroiditis
Clinical narrative: developed thyroiditis went to ER following with endocronologist. thinks might be related to vaccine. updating previous report per request
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Thyroiditis
Clinical narrative: developed thyroiditis went to ER following with endocronologist. thinks might be related to vaccine. updating previous report per request
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood thyroid stimulating hormone, Computerised tomogram neck, Dysphagia, Ear infection, Fatigue
Clinical narrative: developed thyroiditis went to ER following with endocronologist. thinks might be related to vaccine. updating previous report per request
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Lymphadenopathy, Myalgia, Neck pain, Pain, Pyrexia
Clinical narrative: developed thyroiditis went to ER following with endocronologist. thinks might be related to vaccine. updating previous report per request
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test, Thyroxine free, Tri-iodothyronine free
Clinical narrative: developed thyroiditis went to ER following with endocronologist. thinks might be related to vaccine. updating previous report per request
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Mass, Pain in extremity, Swelling
Clinical narrative: FELT PAINFUL; RED MARK WHICH GOT INCREASED; SWELLING WHICH GOT INCREASED; This spontaneous report received from a patient concerned a 34 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A, expiry: UNKNOWN) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 07-APR-2021, the subject experienced felt painful. On 07-APR-2021, the subject experienced red mark which got increased. On 07-APR-2021, the subject experienced swelling which got increased. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from red mark which got increased, swelling which got increased, and felt painful. This report was non-serious.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Pain, Swelling
Clinical narrative: FELT PAINFUL; RED MARK WHICH GOT INCREASED; SWELLING WHICH GOT INCREASED; This spontaneous report received from a patient concerned a 34 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A, expiry: UNKNOWN) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 07-APR-2021, the subject experienced felt painful. On 07-APR-2021, the subject experienced red mark which got increased. On 07-APR-2021, the subject experienced swelling which got increased. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from red mark which got increased, swelling which got increased, and felt painful. This report was non-serious.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Dysphonia
Clinical narrative: HOARSE AND BROKEN VOICE; BODY ACHE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On APR-2021, the subject experienced hoarse and broken voice. On APR-2021, the subject experienced body ache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from body ache, and had not recovered from hoarse and broken voice. This report was non-serious.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Dysphonia, Pain
Clinical narrative: HOARSE AND BROKEN VOICE; BODY ACHE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On APR-2021, the subject experienced hoarse and broken voice. On APR-2021, the subject experienced body ache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from body ache, and had not recovered from hoarse and broken voice. This report was non-serious.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Headache, Myalgia, Pyrexia, Sleep disorder, Urticaria
Clinical narrative: FEVER; MUSCLE ACHES (SHOULDERS UP); HEADACHE; LARGE PATCH OF HIVES (SHOULDERS TO WAIST); This spontaneous report received from a patient concerned a 46 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 10-APR-2021, the subject experienced fever. On 10-APR-2021, the subject experienced muscle aches (shoulders up). On 10-APR-2021, the subject experienced headache. On 10-APR-2021, the subject experienced large patch of hives (shoulders to waist). Treatment medications (dates unspecified) included: prednisone, and diphenhydramine hydrochloride. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever, muscle aches (shoulders up), and headache on APR-2021, and large patch of hives (shoulders to waist) on 11-APR-2021. This report was non-serious.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Headache, Myalgia, Pyrexia, Urticaria
Clinical narrative: FEVER; MUSCLE ACHES (SHOULDERS UP); HEADACHE; LARGE PATCH OF HIVES (SHOULDERS TO WAIST); This spontaneous report received from a patient concerned a 46 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 10-APR-2021, the subject experienced fever. On 10-APR-2021, the subject experienced muscle aches (shoulders up). On 10-APR-2021, the subject experienced headache. On 10-APR-2021, the subject experienced large patch of hives (shoulders to waist). Treatment medications (dates unspecified) included: prednisone, and diphenhydramine hydrochloride. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever, muscle aches (shoulders up), and headache on APR-2021, and large patch of hives (shoulders to waist) on 11-APR-2021. This report was non-serious.
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Back pain, Bell's palsy, Blood iron normal, Blood thyroid stimulating hormone normal, C-reactive protein normal
Clinical narrative: The Jansen vaccine was given on 3/18/21. Patient began to experience symptoms of bells palsy on 4/6/21. Patient noted  R hemibody numbness, which began with right-sided facial numbness when brushing teeth. He was evaluated by his PCP (no exam noted) and initiated on Bells Palsy regimen of doxycycline 100mg BID, acyclovir 800mg TID, and prednisone 40mg. On 4/9, a referral to neurology was made after pt returned to clinic w/ burning deep low back pain that radiates up to his shoulder, and his b/l temples. Pt again re-presented to urgent care on 4/12 due to severe burning back pain that resolved w/ activity. At this time again only L sided facial weakness noted (documented as reduced ability to close eyelid, raise eyebrow, weakness puffing out check, and reduced smile on L), no other weakness, drift, or sensory findings. Pt was instructed to continue doxycylilne 100mg BID 10d course (4/6- 4/15), prednisone 40mg 7d course (4/6- 4/12), acyclovir 800mg TID 7d course(4/6-4/12).
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Full blood count normal, Headache, Lipase normal, Metabolic function test, Pain
Clinical narrative: The Jansen vaccine was given on 3/18/21. Patient began to experience symptoms of bells palsy on 4/6/21. Patient noted  R hemibody numbness, which began with right-sided facial numbness when brushing teeth. He was evaluated by his PCP (no exam noted) and initiated on Bells Palsy regimen of doxycycline 100mg BID, acyclovir 800mg TID, and prednisone 40mg. On 4/9, a referral to neurology was made after pt returned to clinic w/ burning deep low back pain that radiates up to his shoulder, and his b/l temples. Pt again re-presented to urgent care on 4/12 due to severe burning back pain that resolved w/ activity. At this time again only L sided facial weakness noted (documented as reduced ability to close eyelid, raise eyebrow, weakness puffing out check, and reduced smile on L), no other weakness, drift, or sensory findings. Pt was instructed to continue doxycylilne 100mg BID 10d course (4/6- 4/15), prednisone 40mg 7d course (4/6- 4/12), acyclovir 800mg TID 7d course(4/6-4/12).
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Pain in extremity, Prostatic specific antigen normal, Protein total increased, Protein urine present, Red blood cell sedimentation rate normal
Clinical narrative: The Jansen vaccine was given on 3/18/21. Patient began to experience symptoms of bells palsy on 4/6/21. Patient noted  R hemibody numbness, which began with right-sided facial numbness when brushing teeth. He was evaluated by his PCP (no exam noted) and initiated on Bells Palsy regimen of doxycycline 100mg BID, acyclovir 800mg TID, and prednisone 40mg. On 4/9, a referral to neurology was made after pt returned to clinic w/ burning deep low back pain that radiates up to his shoulder, and his b/l temples. Pt again re-presented to urgent care on 4/12 due to severe burning back pain that resolved w/ activity. At this time again only L sided facial weakness noted (documented as reduced ability to close eyelid, raise eyebrow, weakness puffing out check, and reduced smile on L), no other weakness, drift, or sensory findings. Pt was instructed to continue doxycylilne 100mg BID 10d course (4/6- 4/15), prednisone 40mg 7d course (4/6- 4/12), acyclovir 800mg TID 7d course(4/6-4/12).
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test negative, Treponema test negative, Vitamin B12 normal
Clinical narrative: The Jansen vaccine was given on 3/18/21. Patient began to experience symptoms of bells palsy on 4/6/21. Patient noted  R hemibody numbness, which began with right-sided facial numbness when brushing teeth. He was evaluated by his PCP (no exam noted) and initiated on Bells Palsy regimen of doxycycline 100mg BID, acyclovir 800mg TID, and prednisone 40mg. On 4/9, a referral to neurology was made after pt returned to clinic w/ burning deep low back pain that radiates up to his shoulder, and his b/l temples. Pt again re-presented to urgent care on 4/12 due to severe burning back pain that resolved w/ activity. At this time again only L sided facial weakness noted (documented as reduced ability to close eyelid, raise eyebrow, weakness puffing out check, and reduced smile on L), no other weakness, drift, or sensory findings. Pt was instructed to continue doxycylilne 100mg BID 10d course (4/6- 4/15), prednisone 40mg 7d course (4/6- 4/12), acyclovir 800mg TID 7d course(4/6-4/12).
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Arthralgia, Back pain, Bell's palsy, Eyelid function disorder, Facial paresis
Clinical narrative: The Jansen vaccine was given on 3/18/21. Patient began to experience symptoms of bells palsy on 4/6/21. Patient noted  R hemibody numbness, which began with right-sided facial numbness when brushing teeth. He was evaluated by his PCP (no exam noted) and initiated on Bells Palsy regimen of doxycycline 100mg BID, acyclovir 800mg TID, and prednisone 40mg. On 4/9, a referral to neurology was made after pt returned to clinic w/ burning deep low back pain that radiates up to his shoulder, and his b/l temples. Pt again re-presented to urgent care on 4/12 due to severe burning back pain that resolved w/ activity. At this time again only L sided facial weakness noted (documented as reduced ability to close eyelid, raise eyebrow, weakness puffing out check, and reduced smile on L), no other weakness, drift, or sensory findings. Pt was instructed to continue doxycylilne 100mg BID 10d course (4/6- 4/15), prednisone 40mg 7d course (4/6- 4/12), acyclovir 800mg TID 7d course(4/6-4/12).
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Headache, Hypoaesthesia, Pain, Swelling face
Clinical narrative: The Jansen vaccine was given on 3/18/21. Patient began to experience symptoms of bells palsy on 4/6/21. Patient noted  R hemibody numbness, which began with right-sided facial numbness when brushing teeth. He was evaluated by his PCP (no exam noted) and initiated on Bells Palsy regimen of doxycycline 100mg BID, acyclovir 800mg TID, and prednisone 40mg. On 4/9, a referral to neurology was made after pt returned to clinic w/ burning deep low back pain that radiates up to his shoulder, and his b/l temples. Pt again re-presented to urgent care on 4/12 due to severe burning back pain that resolved w/ activity. At this time again only L sided facial weakness noted (documented as reduced ability to close eyelid, raise eyebrow, weakness puffing out check, and reduced smile on L), no other weakness, drift, or sensory findings. Pt was instructed to continue doxycylilne 100mg BID 10d course (4/6- 4/15), prednisone 40mg 7d course (4/6- 4/12), acyclovir 800mg TID 7d course(4/6-4/12).